
    
      Screening: within 90 days Period of treatment: 24 weeks (including 13 bi-weekly infusions)
      Post treatment evaluation visit: 2 weeks after last neoGAA infusion (at Week 27) End of study
      visit: 4 weeks after last neoGAA infusion (at Week 29) Total duration: approximately 41 weeks
    
  